登入選單
返回Google圖書搜尋
Attorney General Opinion No. 1989-074
註釋Although the proposed drug bid program raises serious antitrust questions, it is our opinion that it does not represent a p̲e̲r̲ ̲s̲e̲ violation of antitrust laws. Under a rule of reason analysis the proposed bid program may survive an antitrust challenge. The proposed program should be conducted in a manner that renders the market more, rather than less, competitive and does not allow one manufacturer to unlawfully possess market power to the exclusion of its competitors. Cited herein: 15 U.S.C. section 1-27.